Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiraz El Adam

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Health Science Reports|August 5, 2024
Surrogate endpoints for neonatal outcome: A rapid reviewShiraz El Adam, Karissa Johnston, Maanasa Venkataraman, et al.
Health Reports|January 20, 2022
Why are babies in Canada getting smaller?Shiraz El Adam, Jennifer A Hutcheon, Chris McLeod, et al.
BMJ Open|January 23, 2023
Impact of cancer on income, wealth and economic outcomes of adult cancer survivors: a scoping reviewColene Bentley, Paulos Teckle, Lisa McQuarrie, et al.
BMJ Open|September 17, 2021
Impact of a cancer diagnosis on the income of adult cancer survivors: a scoping review protocolShiraz El Adam, Colene Bentley, Lisa McQuarrie, et al.
Journal of the American Medical Directors Association|December 28, 2020
Dementia and Poor Continuity of Primary Care Delay Hospital Discharge in Older Adults: A Population-Based Study From 2001 to 2016Mari Aaltonen, Shiraz El Adam, Anne Martin-Matthews, et al.
Open Forum Infectious Diseases|May 9, 2022
SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, CanadaShiraz El Adam, Macy Zou, Shinhye Kim, et al.
Future Oncology (London, England)|September 13, 2024
Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionalsAnna Sureda, Shiraz El Adam, Shibing Yang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2021
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, CanadaDanuta M Skowronski, Solmaz Setayeshgar, Macy Zou, et al.
The Journal of Infectious Diseases|January 27, 2022
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, CanadaDanuta M Skowronski, Solmaz Setayeshgar, Macy Zou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, CanadaDanuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Health Science Reports|August 5, 2024
Surrogate endpoints for neonatal outcome: A rapid reviewShiraz El Adam, Karissa Johnston, Maanasa Venkataraman, et al.
Health Reports|January 20, 2022
Why are babies in Canada getting smaller?Shiraz El Adam, Jennifer A Hutcheon, Chris McLeod, et al.
BMJ Open|January 23, 2023
Impact of cancer on income, wealth and economic outcomes of adult cancer survivors: a scoping reviewColene Bentley, Paulos Teckle, Lisa McQuarrie, et al.
BMJ Open|September 17, 2021
Impact of a cancer diagnosis on the income of adult cancer survivors: a scoping review protocolShiraz El Adam, Colene Bentley, Lisa McQuarrie, et al.
Journal of the American Medical Directors Association|December 28, 2020
Dementia and Poor Continuity of Primary Care Delay Hospital Discharge in Older Adults: A Population-Based Study From 2001 to 2016Mari Aaltonen, Shiraz El Adam, Anne Martin-Matthews, et al.
Open Forum Infectious Diseases|May 9, 2022
SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, CanadaShiraz El Adam, Macy Zou, Shinhye Kim, et al.
Future Oncology (London, England)|September 13, 2024
Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionalsAnna Sureda, Shiraz El Adam, Shibing Yang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2021
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, CanadaDanuta M Skowronski, Solmaz Setayeshgar, Macy Zou, et al.
The Journal of Infectious Diseases|January 27, 2022
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, CanadaDanuta M Skowronski, Solmaz Setayeshgar, Macy Zou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, CanadaDanuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
Pageof 1